Hallmarks of Cancer: Enabling Replicative Immortality


Posted by Chris S on Apr 17, 2019 3:10:00 AM

Cancer cells can revert to a pre-differentiated, stem-cell-like phenotype, allowing uninhibited cellular division and other metabolic adaptations that enable survival in adverse conditions.

READ MORE >

Topics: Cell Biology, Cancer Research

Hallmarks of Cancer: Sustaining Proliferative Signaling


Posted by Chris S on Apr 3, 2019 3:15:00 AM

Cancer cells stimulate their own growth, which means they become self-sufficient in growth signals, and no longer depend on external signals (like Epidermal Growth Factor EGF/ EGFR). Proliferation depends highly on these three important pathways: Akt, MAPK/Erk, and MTOR.

READ MORE >

Topics: Cell Biology, Cancer Research

Hallmarks of Cancer: Inducing Angiogenesis Energetics


Posted by Chris S on Mar 20, 2019 3:15:00 AM

Cancer cells stimulate the growth of blood vessels to supply nutrients to tumors. Angiogenesis is the formation of new blood vessels from pre-existing blood vessels. This plays an important role in tumor growth.

READ MORE >

Topics: Cell Biology, Cancer Research

Hallmarks of Cancer: Deregulating Cellular Energetics


Posted by Chris S on Feb 27, 2019 3:15:00 AM

Cancer cells need a lot of energy to grow fast—to do so, they show abnormal metabolic pathways.

READ MORE >

Topics: Cell Biology, Cancer Research

Hallmarks of Cancer: Resisting Cell Death


Posted by Chris S on Jan 23, 2019 3:15:00 AM

One thing we know about cancer cells: they can resist death. They evade apoptosis, the mechanism that programs cell death once cells become damaged. Normally, apoptosis helps keep an organism healthy through growth and development, maintaining body tissue by removing infected or damaged cells. But cancer cells do not follow this process, no matter how abnormally they grow.

READ MORE >

Topics: Cancer Research

Demystifying Multiplex IHC


Posted by Jen Z on Oct 10, 2018 3:15:00 AM

In recent years, immune checkpoint proteins in the tumor microenvironment have been under intense study. If you work in the immuno-oncology field, chances are you are either performing multiplex IHC (mIHC) or would like to. Ultimately, a multiplexed image like the one featured here provides a multi-layered depiction of a tumor, such that each antibody corresponds to a different fluorescent signal. If you want to detect more targets in your IHC, but aren’t sure how to design a panel of antibodies and fluorophores for mIHC, we’ll walk you through the process in this post.

READ MORE >

Topics: IHC, Cancer Research, mIHC, techniques, Immunology

2018 Nobel Prize Awarded to Immunotherapy Pioneers


Posted by Cell Signaling Technology on Oct 3, 2018 3:00:00 AM

Earlier this week, Dr. James Allison and Dr. Tasuku Honjo were announced as joint winners of the 2018 Nobel Prize in Physiology or Medicine for their work in the field of immunotherapy and checkpoint immune regulation. Their studies have sparked decades of clinical advances, and changed the future of cancer therapy. A webinar presented by Dr. Allison in conjunction with Dr. Gordon Freeman and Dr. Philip Gotwals is featured in this week's blog post.

READ MORE >

Topics: Cancer Immunology, Cancer Research, Webinars, Immunotherapy

Video: Understanding Macrophages in the Tumor Microenvironment


Posted by Ken B on Sep 19, 2018 3:15:00 AM

Research trends in macrophage plasticity

It’s an exciting time for immuno-oncology research, as potential predictive biomarkers from an expanding collection of cell types are being pursued. Explore the plasticity of tumor-associated macrophages (TAMs) and challenges in distinguishing M1- versus M2- functional states in this 5-minute video featuring CST Developmental Scientist Sarah Klein, PhD. 

Can't see the embedded video? Click here to watch.

READ MORE >

Topics: Cancer Research, Immunology, Immunotherapy

Targeting Cancer Pathways - Tumor Metabolism and Proliferation


Posted by Carolyn P on Jul 25, 2018 3:10:00 AM


Cell Signaling Technology is proud to partner with the Koch Institute at MIT, Science, and Science Signaling to present the Targeting Cancer Pathways webinar series. These webinars will bring together thought leaders from around the world to share current findings and further cancer research community collaboration.

READ MORE >

Topics: Cancer Research, Webinars

GPNMB: A Promising Immunotherapeutic Target for Triple Negative Breast Cancer


Posted by Amrik S. on Apr 4, 2018 3:00:00 AM

The last few years have witnessed several breakthroughs in the immuno-oncology space. Treatments that harness the body’s immune system to fight cancer have transitioned from speculation to offering endless possibilities for drug discovery. Of these treatments, therapeutic monoclonal antibodies are positioned at the forefront of the immunotherapy revolution, and the FDA has approved several of these monoclonal antibodies to treat cancer.

READ MORE >

Topics: Cancer Immunology, Cancer Research, Therapeutics, Medicine, antibody-drug conjugates, Immunotherapy

Subscribe to Email Updates

Recent Posts